Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways

Xue Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dexian Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Oncogenesis
March 7, 2016
10.1038/oncsis.2016.9
Cited by 24

Related Papers

TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner
|Cell Research|2009|55
HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species
|PLoS ONE|2011|50
Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma
|BMC Cancer|2011|34
An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells
|Cell Research|2009|15